Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Therapeutic drug management immunosuppressants

Design an appropriate therapeutic regimen for the management of immunosuppressive drug complications based on patient-specific information. [Pg.829]

Melphalan is an antineoplastic drug, listed also as a Class I immunosuppressive agent (effective only when given prior to the immune stimulus) [1]. It is used for the treatment of multiple myeloma, ovarian carcinoma, tumors of the testes, chronic granulocytic leukemia, chronic lymphocytic leukemia, seminoma, Ewing s sarcoma, reticulum cell sarcoma, and thymoma [1,2]. Its use as an adjuvant to surgery in the management of primary breast cancer was one of the first illustrations of the therapeutic potential of combined modalities of treatment [3]. [Pg.266]

See other pages where Therapeutic drug management immunosuppressants is mentioned: [Pg.1726]    [Pg.871]    [Pg.453]    [Pg.346]    [Pg.59]    [Pg.595]    [Pg.56]    [Pg.221]    [Pg.543]   
See also in sourсe #XX -- [ Pg.1274 , Pg.1275 , Pg.1276 , Pg.1277 , Pg.1278 , Pg.1279 ]



SEARCH



Drugs management

Immunosuppressant

Immunosuppressant drugs

Immunosuppression

Immunosuppressive drugs

Immunosuppressives

Therapeutic drug management

Therapeutic drugs

© 2024 chempedia.info